Myocardial perfusion tomoscintigraphy is a routine medicine procedure to check for the presence and severity of abnormalities of myocardial perfusion, as well as the extension of infarction residua. However, actual imagery devices (gamma cameras) have low resolution and detection sensitivity. A new semiconductor camera has 8 to 10 time higher detection sensitivity and could allow proportionally diminishing injected activities or recording times. Only one pilot study has been recently published on this type of camera, the D.SPECT camera. This study will compare images recorded during 15 to 20 minutes by conventional cameras and 2 to 4 minutes by D.SPECT camera in patients doing tomoscintigraphy under usual conditions. The purpose is to demonstrate the equivalence of images recorded by two camera types for diagnostic information and the secondary purpose is to demonstrate the superiority of the D.SPECT camera in terms of image quality.
This study will be conducted in Nuclear Medicine departments (Nancy Hospital, Bichat Hospital in Paris, Pasteur private hospital in Toulouse), with D.SPECT camera (Cyclopharma). The D.SPECT camera recording will be realized following the conventional camera recording and will not modify the routine programmed examination. Recording times of D.SPECT camera will be maximum 2 minutes for imaging with a strong activity of technetium-99m labeled dye and maximum 4 minutes for imaging with thallium-201 or with a low activity of technetium-99m labeled dye.6 study groups will be analyzed: 4 groups of patients initially doing stress tomoscintigraphy with thallium-201 (group 1) or with technetium-99m labeled dye and then testing 3 principal injection sequences (group 2, 3, 4), and 2 groups of patients initially doing "myocardial viability" assessment with rest tomoscintigraphy with thallium-201 (group 5) or technetium-99m labeled dye. Recording comparison obtained with 2 cameras will be done according to qualitative and quantitative criteria on image quality and analyzing diagnosis concordance (presence, type and severity of observed abnormalities).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
276
with gamma-camera and D.SPECT camera
with gamma-camera and D.SPECT camera, in Toulouse centre
with gamma-camera and D.SPECT camera, in Nancy centre
with gamma-camera and D.SPECT camera, in Paris centre
rest thallium-201 tomoscintigraphy for myocardial viability assessment
rest technetium-99m tomoscintigraphy for myocardial viability assessment
Service de Médecine Nucléaire, Hôpital de Bichat, Assistance Publique des Hôpitaux de Paris
Paris, France
Service de Médecine Nucléaire, Clinique Louis Pasteur
Toulouse, France
Service de Médecine Nucléaire, Hôpital de Brabois, CHU de Nancy
Vandœuvre-lès-Nancy, France
Ejection fraction of link ventricle
Time frame: day 0
Telesystolic volume of link ventricle
Time frame: day 0
Telediastolic volume of link ventricle
Time frame: day 0
Diagnosis of stress ischemia with Myocardial Tomoscintigraphy data
Time frame: day 0
Area of damaged regions of heart
Time frame: day 0
Global myocardial activity
Time frame: day 0
Qualitative score of image quality
Time frame: day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.